Personalized Cannabinoid Formulations through AI-IoT-Blockchain Synergy

A novel system integrating AI-powered genomic analysis, IoT-connected sensors, and blockchain technology to create personalized cannabinoid formulations tailored to an individual's genotype and preferences.

The original patent disclosed cannabinoid formulations designed to align with an individual's genotype based on a defined list of polymorphisms. However, the existing formulations lack real-time monitoring and adjustment capabilities, and their authenticity and quality control are not ensured. The new inventive concept addresses these limitations by introducing AI-driven analysis, IoT-enabled sensors, and blockchain-based tracking to create a more powerful and effective system.

The new system comprises a genotype-based selection module utilizing AI-powered genomic analysis to identify an individual's optimal cannabinoid ratio. The formulation generation module integrates IoT-connected sensors to monitor and adjust terpene profiles in real-time. A blockchain-based tracking module ensures authenticity and quality control of the formulated product. The system can be further integrated with wearable devices, enabling real-time monitoring of physiological responses to cannabinoid formulations and machine learning-driven analysis of genotype-cannabinoid interactions.

The new claims introduce the synergistic combination of AI, IoT, and blockchain technologies, enabling real-time monitoring and adjustment of terpene profiles, and ensuring authenticity and quality control of the formulated product. This integration of distinct technologies provides a novel and non-obvious solution compared to the original patent.

Alternative embodiments may include the use of different AI algorithms, IoT sensor configurations, or blockchain platforms. Variations could involve integrating additional technologies, such as augmented reality or 5G networks, to further enhance the system's capabilities.

The personalized cannabinoid formulation system has significant commercial potential in the cannabis and healthcare industries, offering a unique solution for tailored therapeutic experiences. The system's ability to ensure authenticity and quality control also addresses a critical need in the cannabis supply chain.